Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Verónica Briz"'
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
Instituto de Salud Carlos III (ISCIII)
Hepatitis C virus (HCV) is the primary etiologic agent of liver cirrhosis or hepatocellular carcinoma. HCV elevated infection rates are mostly due to the lack of an accurate and accessible screening and diagnosis, especially in low- and middle-income
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bc6e83da8c2922d5beca4b697dab8a7
http://hdl.handle.net/20.500.12105/11912
http://hdl.handle.net/20.500.12105/11912
Autor:
Salvador Resino, Marta Sánchez-Carrillo, Irene Mate-Cano, Verónica Briz, Claudia Palladino, Beatriz Esteban-Cartelle
Publikováno v:
Enfermedades infecciosas y microbiologia clinica (English ed.). 36:262-267
Resistance-associated substitutions (RASs) to the new HCV NS5A inhibitor elbasvir may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients. There are no data outside clinical trials evaluating their prevalence and impact i
Autor:
Verónica Briz, Claudia Palladino, Irene Mate-Cano, Marta Sánchez-Carrillo, Mónica Gutiérrez-Rivas, María Ángeles Jiménez-Sousa, Salvador Resino, Sonia Vázquez-Morón
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-6 (2017)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repisalud
Instituto de Salud Carlos III (ISCIII)
Scientific Reports
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repisalud
Instituto de Salud Carlos III (ISCIII)
Scientific Reports
Relevant resistance-associated substitutions (RASs) to elbasvir, the new HCV NS5A inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients. There are few data outside clinical trials evaluating their prevalence
Autor:
Amanda Fernández-Rodríguez, Juan Berenguer, José Ma Bellón, Daniel Pineda-Tenor, Mónica García–Alvarez, Jorge Barrera, Cristina Diez, Teresa Aldámiz-Echevarría, María Ángeles Jiménez-Sousa, Verónica Briz, Salvador Resino
Publikováno v:
Infection, Genetics and Evolution. 36:339-344
Toll-like receptor 8 (TLR8) polymorphisms have been related to hepatitis C virus (HCV) infection. The aim was to estimate the association of TLR8 polymorphisms with HCV-related outcomes in HIV/HCV coinfected patients. We performed a cross-sectional s
Autor:
Ifeanyi Jude Ezeonwumelu, Nuno Taveira, Pedro Borrego, Rui Tato Marinho, Verónica Briz, Claudia Palladino, Rute Marcelino, Fátima Serejo, Inês Moranguinho, José Velosa
Publikováno v:
Scientific Reports
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repisalud
Instituto de Salud Carlos III (ISCIII)
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repisalud
Instituto de Salud Carlos III (ISCIII)
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Any successful strategy to prevent and control HCV infection requires an understanding of the epidemic behaviour among the different genotypes. Here, we performed the first characterization of the epidemic history and transmission dynamics of HCV sub
Autor:
Cristina Diez, María Guzmán-Fulgencio, Ana Carrero, Juan Berenguer, S. Vázquez, Verónica Briz, Francisco Tejerina, Teresa Aldámiz-Echevarría, Mónica García-Álvarez, Salvador Resino, Daniel Pineda-Tenor, María Ángeles Jiménez-Sousa
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 34:385-393
Interleukin-7 (IL-7) is a critical factor in maintaining or inducing effective antiviral CD4+ and CD8+ T-cell responses. The aim of this study was to examine the association of interleukin-7 receptor-α (IL7RA) polymorphisms with a sustained virologi
Autor:
Verónica Briz, P. Richard Harrigan, Mónica Gutiérrez-Rivas, Salvador Resino, Sonia Vázquez-Morón, Alejandro Álvaro-Meca, Mónica García-Álvarez, María Ángeles Jiménez-Sousa, Cesare Giovanni Fedele
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
PLoS ONE
PLoS ONE, Vol 11, Iss 9, p e0163197 (2016)
Repisalud
Instituto de Salud Carlos III (ISCIII)
Consejería de Sanidad de la Comunidad de Madrid
PLoS ONE
PLoS ONE, Vol 11, Iss 9, p e0163197 (2016)
Repisalud
Instituto de Salud Carlos III (ISCIII)
BACKGROUND: Resistance-associated variants have been related to treatment failure of hepatitis C virus (HCV) therapy with direct-acting antiviral drugs. The aim of our study was to analyze the prevalence of clinically relevant resistance-associated v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bee2de760273f86b54c9c9ebd67f4ee5
https://repositoriosaludmadrid.es/handle/20.500.12530/25127
https://repositoriosaludmadrid.es/handle/20.500.12530/25127